nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical features and distribution of the APC variant in duodenal and ampullary polyps in patients with familial adenomatous polyposis: a multicenter retrospective cohort study in Japan
|
Miyakura, Yasuyuki |
|
|
29 |
2 |
p. 169-178 |
artikel |
2 |
Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery based on dispersion of recurrence probability
|
Yamashita, Tsuyoshi |
|
|
29 |
2 |
p. 222-231 |
artikel |
3 |
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer
|
Mouri, Atsuto |
|
|
29 |
2 |
p. 124-133 |
artikel |
4 |
Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis
|
Matsushita, Yuto |
|
|
29 |
2 |
p. 205-212 |
artikel |
5 |
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing
|
Wakuda, Kazushige |
|
|
29 |
2 |
p. 96-102 |
artikel |
6 |
Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study
|
Wei, Zhi-jian |
|
|
29 |
2 |
p. 149-158 |
artikel |
7 |
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study
|
Nagashima, Shuhei |
|
|
29 |
2 |
p. 188-194 |
artikel |
8 |
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients
|
Yoshimoto, Takanori |
|
|
29 |
2 |
p. 142-148 |
artikel |
9 |
Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)
|
Kawase, Tomono |
|
|
29 |
2 |
p. 134-141 |
artikel |
10 |
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma
|
Goto, Hideki |
|
|
29 |
2 |
p. 232-240 |
artikel |
11 |
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial
|
Ishimaru, Sae |
|
|
29 |
2 |
p. 89-95 |
artikel |
12 |
Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC
|
Harimoto, Norifumi |
|
|
29 |
2 |
p. 195-204 |
artikel |
13 |
Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: a multicenter retrospective cohort study
|
Nakao, Eiichi |
|
|
29 |
2 |
p. 179-187 |
artikel |
14 |
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy
|
Terashima, Yuto |
|
|
29 |
2 |
p. 115-123 |
artikel |
15 |
Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy
|
Nishimura, Goshi |
|
|
29 |
2 |
p. 103-114 |
artikel |
16 |
Robotic systems in interventional oncology: a narrative review of the current status
|
Matsui, Yusuke |
|
|
29 |
2 |
p. 81-88 |
artikel |
17 |
Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis
|
Shimomura, Tatsuya |
|
|
29 |
2 |
p. 213-221 |
artikel |
18 |
Survival outcomes of patients with stage III colorectal cancer aged ≥ 80 years who underwent curative resection: the HiSCO-04 prospective cohort study
|
Mochizuki, Tetsuya |
|
|
29 |
2 |
p. 159-168 |
artikel |